EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance

Shannalee R Martinez, Catherine C Elix, Pedro T Ochoa, Evelyn S Sanchez-Hernandez, Hossam R Alkashgari, Greisha L Ortiz-Hernandez, Lubo Zhang iD, Carlos A Casiano iD

International Journal of Molecular Sciences · 12.04.2023 · 24 (8) · 7130

DOI: 10.3390/ijms24087130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.04.2023. Verfasst von Shannalee R Martinez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA 92350, …. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Prostatic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapy resistance hinders the efficacy of anti-androgen therapies and taxane-based chemotherapy for advanced prostate cancer (PCa). Glucocorticoid receptor (GR) signaling mediates resistance to androgen receptor signaling inhibitors (ARSI) and has also been recently implicated in PCa resistance to docetaxel (DTX), suggesting a role in therapy cross-resistance. Like GR, β-catenin is upregulated in metastatic and therapy-resistant tumors and is a crucial regulator of cancer stemness and ARSI resistance. β-catenin interacts with AR to promote PCa progression. Given the structural and functional similarities between AR and GR, we hypothesized that β-catenin also interacts with GR to influence PCa stemness and chemoresistance. As expected, we observed that treatment with the glucocorticoid dexamethasone promotednuclear accumulation of GR and active β-catenin in PCa cells. Co-immunoprecipitation studies showed that GR and β-catenin interact in DTX-resistant and DTX-sensitive PCa cells. Pharmacological co-inhibition of GR and β-catenin, using the GR modulator CORT-108297 and the selective β-catenin inhibitor MSAB, enhanced cytotoxicity in DTX-resistant PCa cells grown in adherent and spheroid cultures and decreased CD44+/CD24– cell populations in tumorspheres. These results indicate that GR and β-catenin influence cell survival, stemness, and tumorsphere formation in DTX-resistant cells. Their co-inhibition could be a promising therapeutic strategy to overcome PCa therapy cross-resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidProstatic NeoplasmsMaleHumansDocetaxelbeta CateninCell Line, TumorDrug Resistance, Neoplasm

Stichwörter der Autor:innen

docetaxelglucocorticoid receptorprostate cancerstemnesstumorspheresβ-catenin

Substanzen

DocetaxelReceptors, Glucocorticoidbeta Catenin

Autor:innen und Institutionen

  • Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
  • Department of Physiology, School of Medicine, University of Jeddah, Jeddah 21589, Saudi Arabia.
  • Lawrence D. Longo MD Center for Perinatal Biology, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
  • Department of Medicine, Rheumatology Division, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.

ORCID-Profile: Lubo Zhang, Carlos A Casiano

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • NIH grants
  • Loma Linda University Center for Health Disparities and Molecular Medicine

Zitieren

APA

Martinez, S. R., Elix, C. C., Ochoa, P. T., Sanchez-Hernandez, E. S., Alkashgari, H. R., Ortiz-Hernandez, G. L., Zhang, L., & Casiano, C. A. (2023). Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance. International Journal of Molecular Sciences, 24(8), 7130. https://doi.org/10.3390/ijms24087130

Vancouver

Martinez SR, Elix CC, Ochoa PT, Sanchez-Hernandez ES, Alkashgari HR, Ortiz-Hernandez GL, et al. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance. International Journal of Molecular Sciences. 2023;24(8):7130. doi:10.3390/ijms24087130

BibTeX
@article{Martinez2023,
  author = {Martinez, Shannalee R and Elix, Catherine C and Ochoa, Pedro T and Sanchez-Hernandez, Evelyn S and Alkashgari, Hossam R and Ortiz-Hernandez, Greisha L and Zhang, Lubo and Casiano, Carlos A},
  title = {Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {7130},
  doi = {10.3390/ijms24087130}
}
Kostenlos starten →